References

Abernethy DR, Greenblatt DJ, Shader RI (1985) Imipramine and desipramine disposition in the

elderly. J Pharmacol Exp Ther 232(1):183–188

Alagiakrishnan K, Wiens CA (2004) An approach to drug induced delirium in the elderly. Postgrad

Med J 80:388–393

Allard P, Gram L, Timdahl K, Behnke K, Hanson M, Sogaard J (2004) Efficacy and tolerability of

venlafaxine in geriatric outpatients with major depression: a double-blind, randomized 6-month

comparative trial with citalopram. Int J Geriatr Psychiatry 19(12):1123–1130

Altamura AC, Moro AR, Percudani M (1994) Clinical pharmacokinetics of fluoxetine. Clin

Pharmacokinet 26(3):201–214

Antal EJ, Lawson IR, Alderson LM, Chapron DJ, Kramer PA (1982) Estimating steady state

desipramine levels in noninstitutionalized elderly patients using single dose disposition

parameters. J Clin Psychopharmacol 2(3):193–198

Bahar MA, Wang Y, Bos JHJ, Wilffert B, Hak E (2018) Discontinuation and dose adjustment of

metoprolol

after

metoprolol-paroxetine/fluoxetine

co-prescription

in

Dutch

elderly.

Pharmacoepidemiol Drug Saf 27:621–629

Bai JP, Burckart FBP, Mulberg AE (2016) Literature review of gastrointestinal physiology in the

elderly, in pediatric patients, and in patients with gastrointestinal diseases. J Pharm Sci 105(2):

476–483

Barua A, Ghosh MK, Kar N, Basilio MA (2011) Prevalence of depression in the elderly. Ann Saudi

Med 31(6):620–624

Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Vryan JF (2019) Making sense of the

microbiome in psychiatry. Int J Neuropsychopharmacol 22(1):37–52

Bauer M, Wulkersdorfer B, Karch R, Philippe C, Jager W, Stanek J, Wadsak W, Hacker M,

Zeitlinger M, Langer O (2017) Effect of P-glycoprotein inhibition at the blood-brain barrier

on brain distribution of (R)-[(11) C]verapamil in elderly vs. young subjects. Br J Clin Pharmacol

83(9):1991–1999

Begg EJ, Sharman JR, Kidd JE, Sainsbury R, Clark DWJ (1989) Br J Clin Pharmacol 27:445–451

Benetello P, Furlanut M, Zara G, Baraldo M (1990) Imipramine pharmacokinetics in depressed

geriatric patients. Int J Clin Pharmacol Res 10(3):191–195

Berg UB (2006) Differences in decline in GFR with age between males and females. Reference data

on clearances if inulin and PAH in potential kidney donors. Nephrol Dial Transplant 21:2577–

2582

Bergmann JF, Laneury JP, Duchenne P, Fleishaker JC, Houin G, Segrestaa JM (2000) Pharmaco-

kinetics of reboxetine in healthy elderly volunteers. Eur J Drug Metab Pharmacokinet 25(3–4):

195–198

Bezchlibnyk-Butler K, Aleksic I, Kennedy SH (2000) Citalopram: a review of pharmacological and

clinical effects. J Psychiatry Neurosci 25(3):241–254

Bhattacharjee S, Lukiw WJ (2013) Alzheimer’s disease and the microbiome. Front Cell Neurosci

153(7):1–4. https://doi.org/10.3389/fncel.2013.00153

Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkila J, Monti D, Satokari R,

Franceschi C, Brigidi P, De Vos W (2010) Through ageing, and beyond: gut microbiota and

inflammatory status in seniors and centenarians. PLoS ONE 5(5):e10667. https://doi.org/10.

1371/journal.pone.0010667

Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S,

Scurti M, Monti D, Capri M, Brigidi P, Candela M (2016) Gut microbiota and extreme

longevity. Curr Biol 26(11):1480–1485

Birnbaum A, Hardie NA, Leppik IE, Conway JM, Bowers SE, Lackner T, Graves NM (2003)

Variability of total phenytoin serum concentrations within elderly nursing home residents.

Neurology 60(4):555–559

15

The Importance of Drug Dose Adjustment in Elderly Patients with Special. . .

265